<DOC>
	<DOCNO>NCT01089868</DOCNO>
	<brief_summary>The aim study establish FET-PET additional therapy assessment parameter patient diagnose glioblastoma multiforme receive radiochemotherapy adjuvant chemotherapy previous resection biopsy .</brief_summary>
	<brief_title>Usefulness Therapy Monitoring Means ( 18 ) FFluoroethyltyrosine-Positron Emission Tomography ( FET-PET ) Glioblastoma Multiforme Patients</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>neuroradiologically suspect Glioblastoma multiforme histological verification obtain either microsurgery stereotactic biopsy . The neuropathological diagnosis verify reference neuropathologist patient undergo radiochemotherapy subsequent surgical procedure patient older 18 year Karnofsky Performance Score &gt; =70 pregnant nursing female patient include study safe contraceptive method radiochemotherapy chemotherapy patient informed consent obtain due organic brain syndrome insufficient language skill patient lie quiet time period app . two hour FETPEt scan medical history metastatic brain disease patient MRI scan perform due claustrophobia metallic protheses pacemaker etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Glioblastoma multiforme</keyword>
	<keyword>Microsurgery</keyword>
	<keyword>Stereotactic biopsy</keyword>
	<keyword>Radiochemotherapy</keyword>
	<keyword>Temodar</keyword>
	<keyword>FET PET</keyword>
	<keyword>Molecular imaging</keyword>
</DOC>